DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine
4 years, 5 months ago

DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine

Firstpost  

After being denied their request to conduct a phase three clinical trial with Russia’s Sputnik V covid-19 vaccine and asked to submit a new request, the Controller General of Medicines of India has given Dr Reddy’s Laboratories its approval. After the first application was evaluated by the Subject Expert Committee on COVID-19 at Central Drugs Standard Control Organisation, the regulator said Dr Reddy’s cannot directly conduct a phase 3 trial for the COVID-19 vaccine. CDSCO had asked Dr Reddy’s to submit a revised application, which includes new protocols for both phase 2 and phase 3 human clinical trials instead of just phase 3. Kirill Dmitriev, CEO of the Russian Direct Investment Fund said in a statement, “We are delighted to be working with regulatory authorities in India and will provide data on the safety and immunogenicity of the vaccine from Phase 3 trials in Russia, in addition to data from clinical trials in India to facilitate successful Sputnik V trials in the country.” India, overlooked by Dr Reddy’s will be conducting a multicenter, randomized controlled trial, which will include safety and immunogenicity trials.

India Russia Trial Trials Clinical Trials Phase Vaccine Dcgi Clinical Phase 3 Phase 2 Sputnik Dr Reddy  phase  trials  dr  request  dcgi  india  sputnik  safety  trial  vaccine  reddys  russias  v  clinical

History of this topic

Ensure testing for monkeypox, Health Ministry tells States
2 years, 8 months ago

Ensure testing for monkeypox, Health Ministry tells States

The Hindu  

The Union Health Ministry in its communication to stakeholders on Thursday said that while COVID-19 pandemic continues to pose challenges, it is vital that States remain aware, alert and ready to tackle other public health threats like Monkeypox which is on the rise globally. They are also advised to reach out to beneficiaries to take the precaution dose Monkeypox awareness …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 9 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
2 years, 9 months ago

Bharat Biotech's COVID-19 nasal vaccine phase III trials completed

India TV News  

Bharat Biotech's COVID-19 nasal vaccine phase III trials completed Krishna was in Paris as a speaker at Viva Technology 2022 where India was declared country of the year. Highlights Clinical phase III trials of COVID-19 nasal vaccine have been completed Bharat Biotech will submit its data with DCGI next month India was declared country of the year at Viva Technology …

1st Dose to Be Given as Booster to Those Vaccinated with Sputnik V, NTAGI Recommends
2 years, 10 months ago

1st Dose to Be Given as Booster to Those Vaccinated with Sputnik V, NTAGI Recommends

News 18  

The first dose of Sputnik V vaccine can be administered as the precaution dose to all those vaccinated with the Russian Covid-19 jab, an NTAGI panel has recommended, official sources told PTI on Saturday. Many Sputnik V recipients who had taken their second dose way back in July last year are unable to get the booster shot. “The NTAGI’s Standing …

1st dose of Sputnik V to be given as booster to those vaccinated with Russian vaccine
2 years, 10 months ago

1st dose of Sputnik V to be given as booster to those vaccinated with Russian vaccine

India Today  

National Technical Advisory Group on Immunisation has given its approval to the first dose of Sputnik Covid-19 vaccine to be administered as a booster dose to all those vaccinated with the Russian vaccine. Two days ago, India Today filed an RTI to find out what was the option for a third dose for those vaccinated with Sputnik V in India. …

Russia registers world\'s first nasal vaccine against COVID-19
2 years, 11 months ago

Russia registers world\'s first nasal vaccine against COVID-19

Deccan Chronicle  

Moscow: Russian Health Ministry has registered the nasal version of Sputnik V, the world's first nasal vaccine against COVID-19. "Russian Health Ministry registers the nasal version of Sputnik V, the world's first nasal vaccine against COVID-19," Sputnik V tweeted on late Friday. In January, the Russian news agency TASS reported that the nasal vaccine against the novel coronavirus infection will …

Russia registers nasal version of Sputnik V, world's first nasal vaccine against COVID-19
2 years, 11 months ago

Russia registers nasal version of Sputnik V, world's first nasal vaccine against COVID-19

India Today  

The Russian Health Ministry has registered the nasal version of its vaccine against coronavirus - Sputnik V. It is the world's first nasal vaccine against COVID-19. The Russian news agency TASS in January reported that the nasal vaccine against the novel coronavirus infection will be in civil circulation and available for Russians within 3-4 months, quoting the director of the …

India's drugs regulator approves phase-3 trial of covid vaccine covovax
2 years, 11 months ago

India's drugs regulator approves phase-3 trial of covid vaccine covovax

India Today  

The Drugs Controller General of India granted permission on Wednesday for conducting the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation had, on March 5, recommended permission for conducting the phase-3 clinical trial for Covovax as a booster dose …

Ukraine war: WHO delays review of Russia’s Sputnik V vaccine
3 years ago

Ukraine war: WHO delays review of Russia’s Sputnik V vaccine

Hindustan Times  

The World Health Organization has delayed the review of Russia's Covid-19 vaccine Sputnik V as Moscow continues its full-scale attack on Ukraine. A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia Addressing a press conference on Wednesday, WHO vaccines expert Dr Mariangela Simao said, "We were supposed to go …

Govt Panel Recommends Permission for Phase-3 Trial of Covovax as Booster Dose in Adults
3 years ago

Govt Panel Recommends Permission for Phase-3 Trial of Covovax as Booster Dose in Adults

News 18  

An expert panel of India’s central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on Sunday. The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for conducting a phase-3 clinical trial of the single-dose …

COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults
3 years ago

COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults

India TV News  

Highlights Govt has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax. An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on Sunday. The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation …

Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose
3 years ago

Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose

India Today  

An expert panel of India’s central drug authority has recommended permission to conduct a phase-3 clinical trial of the single-dose Covid-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday. "The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation, which reviewed the application on Friday after detailed deliberation, recommended granting permission for the …

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer
3 years ago

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer

News 18  

The sanctions imposed by the United States on the Russian Direct Investment Fund, which markets Sputnik V internationally has raised concerns over the manufacturing of the Covid-19 vaccine in India, the second largest producer of the jab after Russia. RDIF is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and …

India's first mRNA vaccine under final trials: Dr V.K. Paul
3 years, 1 month ago

India's first mRNA vaccine under final trials: Dr V.K. Paul

India TV News  

India's first mRNA vaccine under final trials: Dr V.K. Paul Indian Council of Medical Research Director General, Dr Balram Bhargava, said that this is another vaccine which really establishes that India is heading towards becoming a vaccine superpower. Highlights India's first homegrown mRNA vaccine is being developed by Pune-based Gennova Biopharmaceuticals The vaccine is currently under final clinical trials With …

Omicron variant Updates: Religious places reopen in Bihar's Patna, Covid restrictions relaxed
3 years, 1 month ago

Omicron variant Updates: Religious places reopen in Bihar's Patna, Covid restrictions relaxed

India TV News  

Omicron variant LIVE Updates: With daily COVID-19 cases on the decline, the Jammu and Kashmir State Executive Committee on Sunday ended the weekend lockdown and gave one-hour relaxation in the night curfew timings. Meanwhile, the Drugs Controller General of India has granted emergency use permission to single-dose Sputnik Light Covid vaccine in the country, Union Health Minister Mansukh Mandaviya said …

DCGI grants emergency use permission to Sputnik Light COVID-19 vaccine
3 years, 1 month ago

DCGI grants emergency use permission to Sputnik Light COVID-19 vaccine

Firstpost  

Hyderabad-based Dr Reddy’s Laboratories is the Indian partner of the Russian Direct Investment Fund, which has sought approval from the Indian drug regulator for use of single-dose Russia’s Sputnik Light one shot New Delhi: The Drugs Controller General of India has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday. “DCGI …

Single-dose Sputnik Light Covid vaccine gets approval for emergency use in India
3 years, 1 month ago

Single-dose Sputnik Light Covid vaccine gets approval for emergency use in India

India Today  

The Drugs Controller General of India has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine on Sunday. DCGI has granted emergency use permission to Single-dose Sputnik Light COVID-19 vaccine in India. — Dr Mansukh Mandaviya February 6, 2022 An expert panel of India's central drug authority on Friday recommended granting restricted emergency use authorisation to the single-dose Covid-19 …

Single-dose Sputnik Light Covid vaccine receives emergency use approval from DCGI
3 years, 1 month ago

Single-dose Sputnik Light Covid vaccine receives emergency use approval from DCGI

India TV News  

Single-dose Sputnik Light Covid vaccine receives emergency use approval from DCGI Sputnik Light Covid vaccine is the 9th vaccine to be approved for emergency use in India. Highlights Sputnik Light Covid vaccine received emergency use approval on Sunday. Union Health Minister Mansukh Mandaviya on Sunday notified that the single dose Sputnik Light Covid vaccine has received emergency use permission from …

Government panel recommends emergency use authorisation for single-dose COVID-19 jab Sputnik Light
3 years, 1 month ago

Government panel recommends emergency use authorisation for single-dose COVID-19 jab Sputnik Light

Firstpost  

According to Dr Reddy’s Laboratories, the Sputnik Light vaccine is approved in 29 countries, including Argentina, Russia etc New Delhi: An expert panel of India’s central drug authority on 4 February, 2022, recommended granting restricted emergency use authorisation to single-dose COVID-19 vaccine Sputnik Light subject to various regulatory provisions, official sources said. Sputnik Light is the same as component-1 of …

Government panel recommends emergency use authorisation for single-dose COVID jab Sputnik Light
3 years, 1 month ago

Government panel recommends emergency use authorisation for single-dose COVID jab Sputnik Light

India TV News  

Government panel recommends emergency use authorisation for single-dose COVID jab Sputnik Light The interim data of the efficacy trial from Russia has shown an efficacy of 65.4 per cent against COVID-19, 21 days after immunisation. Highlights Expert panel of India's central drug authority recommended restricted EUA to COVID vax Sputnik Light Sputnik Light is the same as component-1 of Sputnik …

Govt panel recommends granting emergency use authorisation to single dose of Covid vaccine Sputnik Light
3 years, 1 month ago

Govt panel recommends granting emergency use authorisation to single dose of Covid vaccine Sputnik Light

India Today  

An expert panel of India's central drug authority on Friday recommended granting restricted emergency use authorisation to the single-dose Covid-19 vaccine Sputnik Light, subject to various regulatory provisions, official sources said. Sputnik Light is the same as component-1 of Sputnik V. According to an official source, in light of the recommendations made during an SEC meeting on January 31, Dr …

Trying to Bring Sputnik M Vaccine for Adolescents to India: Dr Reddy's
3 years, 1 month ago

Trying to Bring Sputnik M Vaccine for Adolescents to India: Dr Reddy's

News 18  

Dr Reddy’s Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia’s Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India. Addressing a press conference after announcing the company’s Q3 results, a senior executive of the drug maker said Phase 3 clinical trial data of Russia’s single dose COVID-19 vaccine Sputnik …

SEC approval for Bharat Biotech\'s COVID booster intranasal vaccine phase 3 trials
3 years, 2 months ago

SEC approval for Bharat Biotech\'s COVID booster intranasal vaccine phase 3 trials

Deccan Chronicle  

New Delhi: The Subject Experts Committee of the Drug Controller General of India on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who have taken both the doses of Covaxin and Covishield. "After detailed deliberation, the SEC 'in principle' agreed for the conduct of both phase …

Expert panel may approve Sputnik Light vaccine for emergency use, discuss trials nasal vax
3 years, 2 months ago

Expert panel may approve Sputnik Light vaccine for emergency use, discuss trials nasal vax

India Today  

The Subject Expert Committee is slated to hold a meeting to provide emergency use authorisation to Russia’s Sputnik Light, the one-shot Covid vaccine, on Tuesday, sources said. The Gamelaya Institute in Moscow, which made the Russian vaccine, said all individuals who had received a single shot of Sputnik Light booster dose developed neutralising antibodies against the Omicron Covid-19 variant, even …

Biological E Gets Govt Go-ahead for Phase 3 Trials of Corbevax as Booster Dose
3 years, 2 months ago

Biological E Gets Govt Go-ahead for Phase 3 Trials of Corbevax as Booster Dose

News 18  

The Drug Controller General of India has given the nod for conducting phase 3 trials to test Biological E’s Covid vaccine Corbevax as booster shots, News18.com has learnt. “The company has been given the go-ahead to conduct phase 3 trials using Corbevax as a booster dose. The approvals have been given for conducting trials on those who will receive first …

Bharat Biotech Seeks DCGI Nod for Trials to Evaluate Efficacy of Covaxin Booster Shot - News18
3 years, 2 months ago

Bharat Biotech Seeks DCGI Nod for Trials to Evaluate Efficacy of Covaxin Booster Shot - News18

News 18  

Bharat Biotech has sought permission from India’s drug regulator to conduct clinical trials for evaluating the efficacy of a third dose of its Covid-19 vaccine, Covaxin. According to a top government official, the indigenous vaccine maker has proposed to conduct clinical trials for Covaxin’s booster shot on 5,000 healthy volunteers, keeping a gap of six months between the second and …

Expert Panel To Meet Today To Discuss Covid-19 Booster
3 years, 3 months ago

Expert Panel To Meet Today To Discuss Covid-19 Booster

ABP News  

New Delhi: The Subject Expert Committee will be meeting today to discuss the requirement of a booster shot for high-risk people, reported ANI. The National Technical Advisory Group on Immunization had held a meeting earlier this week to discuss vaccination for children and additional doses. “The meeting put light on COVID-19 vaccination, additional doses, and vaccination for children but due …

Sputnik light COVID vaccine to be launched in India by December
3 years, 3 months ago

Sputnik light COVID vaccine to be launched in India by December

India TV News  

Sputnik light COVID vaccine to be launched in India by December Russia's Health Ministry will register the Sputnik vaccine for children aged 12-17 on Wednesday, with shots expected to be available at the end of December. Dr Reddy’s Laboratories is the sole distributor of Sputnik V. Russian Direct Investment Fund CEO, Kirill Dmitriev on Wednesday said that the Sputnik light …

What Went Wrong with Full Rollout of Russia’s Sputnik V Vaccine in India
3 years, 3 months ago

What Went Wrong with Full Rollout of Russia’s Sputnik V Vaccine in India

News 18  

Slower than anticipated production of the second dose of Sputnik V, heavy cold storage requirements, pending WHO approval, rising Covid-19 cases in Russia and low demand at private hospitals have put brakes on the complete rollout of the Russian vaccine in India. It means that only one second dose is manufactured for every 5 first doses manufactured.” According to experts …

In Russia, 83% of COVID hospital beds are filled amid surge
3 years, 4 months ago

In Russia, 83% of COVID hospital beds are filled amid surge

Associated Press  

MOSCOW — Nearly 83% of hospital beds designated for COVID-19 patients are filled, Russian authorities said Wednesday, as daily tallies of new infections and deaths remain at all-time highs. Russia’s autumn surge in infections and deaths comes amid low vaccination rates, lax public attitudes toward taking precautions and the government’s reluctance to toughen restrictions. In total, Russia’s state coronavirus task …

Sputnik V Developer Calls for Mandatory Covid-19 Vaccines in Russia as Inoculation Remains Low
3 years, 4 months ago

Sputnik V Developer Calls for Mandatory Covid-19 Vaccines in Russia as Inoculation Remains Low

News 18  

The developer of Russia’s coronavirus vaccine Sputnik V has said Moscow should make jabs mandatory as inoculation rates remain low despite record deaths and campaigning by authorities. Gintsburg said Russia was currently working on developing a nasal vaccine that would “complement” Sputnik V. He said Moscow was also carrying out tests of a version of the Sputnik vaccine for minors. …

Dr Reddy's Expected to Submit Sputnik V Light Trial Data to DCGI in November
3 years, 4 months ago

Dr Reddy's Expected to Submit Sputnik V Light Trial Data to DCGI in November

News 18  

Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18 year old children in two cohorts. Deepak Sapra CEO API and Services Dr. Reddy's said …

Serum Institute seeks DCGI nod for Covid vaccine Covovax
3 years, 4 months ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

India Today  

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government …

Namibia halts use of Sputnik jabs after South Africa HIV fears
3 years, 4 months ago

Namibia halts use of Sputnik jabs after South Africa HIV fears

New Indian Express  

Neighbouring South Africa earlier this week said it would not approve Sputnik V due to concerns it could increase the risk of HIV infection among men, a claim the vaccine's developer says is unfounded. South Africa's health products regulator on Monday said it would not authorise use of Sputnik based on earlier studies testing the safety of a modified form …

Russia struggles to meet global orders for Sputnik V vaccine
3 years, 5 months ago

Russia struggles to meet global orders for Sputnik V vaccine

Associated Press  

CARACAS, Venezuela — Esperita García de Perez got her first vaccination against COVID-19 in May. “I had a long time now, many months, anguished because was going to arrive, then it was not going to arrive, then I was going to have to wait, then I was not going to have to wait,” García de Perez said, adding that “you …

Russia, WHO differ on when approval will come for Sputnik V
3 years, 5 months ago

Russia, WHO differ on when approval will come for Sputnik V

Associated Press  

MOSCOW — Russia is ready to provide up to 300 million doses of its Sputnik V vaccine to the U.N.-backed COVAX initiative, a top Russian official promoting the shot says, even though the World Health Organization hasn’t yet signed off on it and production issues have fanned customers’ concerns worldwide. She said the approval process for Sputnik V is currently …

One-shot Sputnik Light Vaccine Shows 70% Efficacy Against Covid Delta Variant: RDIF
3 years, 5 months ago

One-shot Sputnik Light Vaccine Shows 70% Efficacy Against Covid Delta Variant: RDIF

News 18  

The Russian Direct Investment Fund and Gamaleya Center on Wednesday said one-shot Sputnik Light vaccine demonstrates 70 per cent efficacy against infection with the Delta variant of coronavirus during the first three months after vaccination. Gamaleya Center has submitted an article analysing efficacy of Sputnik Light vaccine against the Delta variant to the medRxiv preprint server for health sciences, RDIF …

WHO says approval for Russia’s Sputnik V vaccine ‘still on hold’
3 years, 5 months ago

WHO says approval for Russia’s Sputnik V vaccine ‘still on hold’

Al Jazeera  

The World Health Organization has said the Emergency Use Listing process for Russia’s Sputnik V COVID-19 vaccine was on hold pending some missing data and legal procedures, which the UN body hopes will be “sorted out quite soon”. Sputnik Light vaccine Meanwhile, the Russian Direct Investment Fund on Wednesday said the one-shot Sputnik Light vaccine, citing its developer, showed 70 …

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax
3 years, 5 months ago

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax

Live Mint  

Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin. The company, meanwhile, has put in an application seeking the nod of the Drugs Controller General of India to conduct the …

Centre permits export of 40 lakh doses of Covid-19 vaccine Sputnik Light manufactured in India to Russia
3 years, 5 months ago

Centre permits export of 40 lakh doses of Covid-19 vaccine Sputnik Light manufactured in India to Russia

India Today  

The government has permitted the export of Russia's single-dose Covid-19 vaccine Sputnik Light domestically produced as the jab has not yet been approved for emergency use in India, sources said on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V, which is being used in India's anti-Covid inoculation programme after getting emergency use authorisation from …

Centre allows export of Russian Sputnik Light Covid-19 vaccine made in India
3 years, 5 months ago

Centre allows export of Russian Sputnik Light Covid-19 vaccine made in India

India TV News  

Centre allows export of Russian Sputnik Light Covid-19 vaccine made in India Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India's anti-COVID inoculation programme after getting emergency use authorisation from India's Drug Regulator in April. The government has permitted the export of Russia's single-dose COVID-19 vaccine Sputnik Light domestically produced …

India Allows Export of Russia’s Sputnik Light Covid Jab Produced by Hyderabad’s Hetero Biopharma
3 years, 5 months ago

India Allows Export of Russia’s Sputnik Light Covid Jab Produced by Hyderabad’s Hetero Biopharma

News 18  

The government has permitted the export of Russia’s single-dose COVID-19 vaccine Sputnik Light domestically produced here, Sputnik V confirmed on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India’s anti-COVID inoculation programme after getting emergency use authorisation from India’s Drug Regulator in April. The Russian ambassador had urged the …

Govt allows export of Russia’s Sputnik Light Covid-19 vaccine made in India
3 years, 5 months ago

Govt allows export of Russia’s Sputnik Light Covid-19 vaccine made in India

Live Mint  

New Delhi: The government has permitted the export of Russia's single-dose COVID-19 vaccine Sputnik Light domestically produced here as the jab has not yet been approved for emergency use in India, sources said on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India's anti-COVID inoculation programme after getting emergency …

Russians flock to Serbia for Western-made COVID-19 vaccines
3 years, 5 months ago

Russians flock to Serbia for Western-made COVID-19 vaccines

Associated Press  

BELGRADE, Serbia — When Russian regulators approved the country’s own coronavirus vaccine, it was a moment of national pride, and the Pavlov family was among those who rushed to take the injection. “We took the Pfizer vaccine because we want to travel around the world,” Nadezhda Pavlova, 54, said after receiving the vaccine last weekend at a sprawling Belgrade vaccination …

Russians flock to Serbia for Western-made COVID-19 vaccines
3 years, 5 months ago

Russians flock to Serbia for Western-made COVID-19 vaccines

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. “We took the Pfizer vaccine because we want to …

Data on Russia's Sputnik V vaccine is still under review for emergency use approval: WHO
3 years, 5 months ago

Data on Russia's Sputnik V vaccine is still under review for emergency use approval: WHO

Firstpost  

The World Health Organization is still reviewing data about Russia’s Sputnik V vaccine as part of hopes that it can be approved by the U.N. health agency for emergency use against coronavirus, but said Tuesday that no decision is imminent. The clarification comes after Russian Health Minister Mikhail Murashko in recent days said that administrative issues were among the main …

WHO still reviewing Sputnik V vaccine, as Russia presses bid
3 years, 5 months ago

WHO still reviewing Sputnik V vaccine, as Russia presses bid

Associated Press  

GENEVA — The World Health Organization is still reviewing data about Russia’s Sputnik V vaccine as part of hopes that it can be approved by the U.N. health agency for emergency use against coronavirus, but said Tuesday that no decision is imminent. The clarification comes after Russian Health Minister Mikhail Murashko in recent days said that administrative issues were among …

WHO Still Reviewing Sputnik V Vaccine For Emergency Use As Russia Presses Bid
3 years, 5 months ago

WHO Still Reviewing Sputnik V Vaccine For Emergency Use As Russia Presses Bid

News 18  

The World Health Organization is still reviewing data about Russias Sputnik V vaccine as part of hopes that it can be approved by the U.N. health agency for emergency use against coronavirus, but said Tuesday that no decision is imminent. The clarification comes after Russias Health Minister Mikhail Murashko in recent days reportedly said that administrative issues were among the …

WHO still reviewing Sputnik V vaccine, as Russia presses bid
3 years, 5 months ago

WHO still reviewing Sputnik V vaccine, as Russia presses bid

India TV News  

WHO still reviewing Sputnik V vaccine, as Russia presses bid The World Health Organisation is still reviewing data about Russia's Sputnik V vaccine as part of hopes that it can be approved by the UN health agency for emergency use against coronavirus, but said Tuesday that no decision is imminent. The World Health Organisation is still reviewing data about Russia's …

India likely to allow export of Sputnik Light COVID shot this month: Report
3 years, 5 months ago

India likely to allow export of Sputnik Light COVID shot this month: Report

Live Mint  

New Delhi: India is likely to allow the export of domestically produced doses of Russia's Sputnik Light COVID-19 vaccine this month, as the shot has yet to be approved in India, two sources with knowledge of the matter told Reuters. Local media have reported that Indian drugmaker Hetero has already manufactured 2 million doses of the single-shot vaccine, for whose …

Discover Related